November 17, 2020 Clinical Research/Diagn.

Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced COVID-19 Community Connect, a program to link federal, state and local governmental entities, public health agencies, academic institutions, workforces, individuals and a network of high-complexity labs to deliver saliva-based... Read more

November 10, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Obtains CE IVD Mark for Its Quick SARS-CoV-2 Multiplex Kit

LOW COST, HIGH-SENSITIVITY DIAGNOSTIC TEST FOR COVID-19 DETECTION Zymo Research was recently granted the CE IVD certification for its Quick SARS-CoV-2 Multiplex Kit. IRVINE, Calif., (Nov. 10, 2020) — Zymo Research announced today that it obtained a CE IVD mark for the Quick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of... Read more

November 10, 2020 Acad, Gov/Utilities Atomic Spectroscopy Clinical Research/Diagn.

Bringing Ultra-High Field MR Imaging from Research to Clinical: SIGNA 7.0T FDA Cleared

Waukesha, WI – November 10, 2020 – GE Healthcare today announced U.S. FDA 510(k) clearance of SIGNA 7.0T magnetic resonance imaging (MRI) scanner, the world’s most powerful FDA-cleared MRI device available. With a magnet approximately five times more powerful than most clinical systems, SIGNA 7.0T https://www.ge.com/news/press-releases/bringing-ultra-high-field-mr-imaging-from-research-to-clinical-signa-70t-fda-cleared Read more

November 5, 2020 Clinical Research/Diagn. M&A, Partnerships

Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform

Patients Receive Results, Education and Next Steps on Their Mobile Phones to Prevent Further Spread of the Disease SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has partnered with Healthvana Inc., the nation’s leading patient platform... Read more

October 29, 2020 Clinical Research/Diagn.

Tampa General Hospital and GE Healthcare's CareComm Saves $40 Million, Cuts 20,000 Excess Days and Reduces Length of Stay

Tampa, FL – October 29, 2020 – Tampa General Hospital (TGH), in partnership with GE Healthcare, reports a $40M reduction of system-wide inefficiencies since launching their CareComm command center with GE’s Command Center Software last August.  Utilizing 20 artificial intelligence applications (aka Tiles), CareComm helps to optimize minute-to-minute patient care operations with real-time actionable information used in CareComm... Read more

October 29, 2020 Clinical Research/Diagn.

Tampa General Hospital and GE Healthcare's CareComm Saves $40 Million, Cuts 20,000 Excess Days and Reduces Length of Stay

Tampa, FL – October 29, 2020 – Tampa General Hospital (TGH), in partnership with GE Healthcare, reports a $40M reduction of system-wide inefficiencies since launching their CareComm command center with GE’s Command Center Software last August.  Utilizing 20 artificial intelligence applications (aka https://www.ge.com/news/press-releases/tampa-general-hospital-and-ge-healthcares-carecomm-saves-40-million-cuts-20000 Read more

October 27, 2020 Clinical Research/Diagn. Lab Top-10 Life Science Tools Other Lab Products/Services

Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings

Thermo Fisher Scientific Expands Direct-to-Patient Clinical Trials Service Offerings End-to-end solution accelerates clinical trials with speed, convenience and quality WALTHAM, Mass., Oct. 27, 2020 /PRNewswire/ — A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates. The comprehensive offering now includes... Read more

October 26, 2020 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Product Launch

PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research Forward

New kit provides highly sensitive and efficient approach for studying mitophagyimpairment in conditions such as Parkinson’s and Alzheimer’s WALTHAM, Mass. – October 26, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective... Read more